HadBD dehydratase from Mycobacterium tuberculosis fatty acid synthase type II : A singular structure for a unique function
Protein Science · 2024
DOI: 10.1002/pro.4964 ↗At a glance
Journal article in Protein Science, 2024. Written by Pascaline Bories and 14 co-authors. Institution: Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UPS), Toulouse, F…. Major MEDLINE topics: Mycobacterium tuberculosis, Tuberculosis. Cited 5 times so far (Crossref); 57 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Ministère de l'Enseignement Supérieur et de la Recherche, MSDAVENIR, Agence Nationale de la Recherche.
Abstract (original language)
Worldwide, tuberculosis is the second leading infectious killer and multidrug resistance severely hampers disease control. Mycolic acids are a unique category of lipids that are essential for viability, virulence, and persistence of the causative agent, Mycobacterium tuberculosis ( Mtb ). Therefore, enzymes involved in mycolic acid biosynthesis represent an important class of drug targets. We previously showed that the (3 R )‐hydroxyacyl‐ACP dehydratase (HAD) protein HadD is dedicated mainly to the production of ketomycolic acids and plays a determinant role in Mtb biofilm formation and virulence. Here, we discovered that HAD activity requires the formation of a tight heterotetramer between HadD and HadB, a HAD unit encoded by a distinct chromosomal region. Using biochemical, structural, and cell‐based analyses, we showed that HadB is the catalytic subunit, whereas HadD is involved in substrate binding. Based on HadBD Mtb crystal structure and substrate‐bound models, we identified determinants of the ultra‐long‐chain lipid substrate specificity and revealed details of structure–function relationship. HadBD Mtb unique function is partly due to a wider opening and a higher flexibility of the substrate‐binding crevice in HadD, as well as the drastically truncated central α‐helix of HadD hotdog fold, a feature described for the first time in a HAD enzyme. Taken together, our study shows that HadBD Mtb , and not HadD alone, is the biologically relevant functional unit. These results have important implications for designing innovative antivirulence molecules to fight tuberculosis, as they suggest that the target to consider is not an isolated subunit, but the whole HadBD complex.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UPS), Toulouse, France.
- Service de TP de Biochimie, Université de Toulouse, Université Toulouse III - Paul Sabatier (UPS), Toulouse, France.
ORCID profiles: Annaïk Quémard
Funding
- Ministère de l'Enseignement Supérieur et de la Recherche
- MSDAVENIR
- Agence Nationale de la Recherche
Cite
APA
Bories, P., Rima, J., Tranier, S., Marcoux, J., Grimoire, Y., Tomaszczyk, M., Launay, A., Fata, K., Marrakchi, H., Burlet-Schiltz, O., Mourey, L., Ducoux-Petit, M., Bardou, F., Bon, C., & Quémard, A. (2024). HadBD dehydratase from Mycobacterium tuberculosis fatty acid synthase type II : A singular structure for a unique function. Protein Science. https://doi.org/10.1002/pro.4964
Vancouver
Bories P, Rima J, Tranier S, Marcoux J, Grimoire Y, Tomaszczyk M, et al. HadBD dehydratase from Mycobacterium tuberculosis fatty acid synthase type II : A singular structure for a unique function. Protein Science. 2024. doi:10.1002/pro.4964
BibTeX
@article{Bories2024,
author = {Bories, Pascaline and Rima, Julie and Tranier, Samuel and Marcoux, Julien and Grimoire, Yasmina and Tomaszczyk, Mathilde and Launay, Anne and Fata, Karine and Marrakchi, Hedia and Burlet-Schiltz, Odile and Mourey, Lionel and Ducoux-Petit, Manuelle and Bardou, Fabienne and Bon, Cécile and Quémard, Annaïk},
title = {HadBD dehydratase from Mycobacterium tuberculosis fatty acid synthase type II : A singular structure for a unique function},
journal = {Protein Science},
year = {2024},
doi = {10.1002/pro.4964}
}
EUVIMED